Retatrutide side effects and safety signals The most common side effects in the Phase 3 trials are gastrointestinal: nausea, vomiting, diarrhoea, and constipation
We found that irrespective of the route of vitamin B12 administration, serum vitamin B12 levels were increased
L., Candy, B., Jones, L., Williams, R., Tookman, A., and King, M
Long-term safety, carcinogenicity risk, and drug interactions in humans are unknown
Dosage prescribed: In clinical trials, people tend to lose more weight on higher doses of semaglutide